1. Home
  2. ULS vs RDY Comparison

ULS vs RDY Comparison

Compare ULS & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ULS
  • RDY
  • Stock Information
  • Founded
  • ULS 1894
  • RDY 1984
  • Country
  • ULS United States
  • RDY India
  • Employees
  • ULS N/A
  • RDY N/A
  • Industry
  • ULS
  • RDY Biotechnology: Pharmaceutical Preparations
  • Sector
  • ULS
  • RDY Health Care
  • Exchange
  • ULS Nasdaq
  • RDY Nasdaq
  • Market Cap
  • ULS 14.6B
  • RDY 11.8B
  • IPO Year
  • ULS 2024
  • RDY N/A
  • Fundamental
  • Price
  • ULS $63.92
  • RDY $14.27
  • Analyst Decision
  • ULS Buy
  • RDY Strong Buy
  • Analyst Count
  • ULS 8
  • RDY 2
  • Target Price
  • ULS $69.25
  • RDY $16.95
  • AVG Volume (30 Days)
  • ULS 949.4K
  • RDY 845.9K
  • Earning Date
  • ULS 11-04-2025
  • RDY 11-04-2025
  • Dividend Yield
  • ULS 0.81%
  • RDY 0.50%
  • EPS Growth
  • ULS 21.42
  • RDY 2.20
  • EPS
  • ULS 1.62
  • RDY 0.79
  • Revenue
  • ULS $2,951,000,000.00
  • RDY $3,897,394,052.00
  • Revenue This Year
  • ULS $6.69
  • RDY $7.33
  • Revenue Next Year
  • ULS $6.24
  • RDY $1.96
  • P/E Ratio
  • ULS $39.53
  • RDY $17.86
  • Revenue Growth
  • ULS 6.92
  • RDY 15.86
  • 52 Week Low
  • ULS $46.79
  • RDY $12.26
  • 52 Week High
  • ULS $74.15
  • RDY $16.19
  • Technical
  • Relative Strength Index (RSI)
  • ULS 41.99
  • RDY 50.54
  • Support Level
  • ULS $62.20
  • RDY $14.07
  • Resistance Level
  • ULS $64.44
  • RDY $14.35
  • Average True Range (ATR)
  • ULS 1.64
  • RDY 0.16
  • MACD
  • ULS 0.07
  • RDY 0.02
  • Stochastic Oscillator
  • ULS 38.91
  • RDY 37.50

About ULS UL Solutions Inc.

UL Solutions is a global leader specializing in a broad range of product testing, inspection, and certification services. UL Solutions is the for-profit branch out of three organizations under the UL Enterprise. TIC operations make up nearly all of UL Solutions' total revenue and are composed of two segments: industrial and consumer. UL Solutions' remaining business includes software and advisory, which complements its core TIC offerings. The firm operates globally.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: